SCM
DALS
Soleus Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-50,000
| Closed | -$487K | – | 95 |
|
|
2022
Q3 | $487K | Hold |
50,000
| – | – | 0.07% | 73 |
|
|
2022
Q2 | $485K | Sell |
50,000
-50,000
| -50% | -$485K | 0.08% | 71 |
|
|
2022
Q1 | $972K | Sell |
100,000
-250,000
| -71% | -$2.43M | 0.13% | 62 |
|
|
2021
Q4 | $3.43M | Hold |
350,000
| – | – | 0.34% | 45 |
|
|
2021
Q3 | $3.44M | Buy |
+350,000
| New | +$3.44M | 0.54% | 44 |
|